Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Characterization of glaucoma-relevant phenotypes in an Angiopoietin-like 7 zebrafish knockout line
Author Affiliations & Notes
  • McKenzie Gillison
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Anna Larson
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Shi Song Rong
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Janey L Wiggs
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Inas F Aboobakar
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   McKenzie Gillison None; Anna Larson None; Shi Song Rong None; Janey Wiggs None; Inas Aboobakar None
  • Footnotes
    Support  American Glaucoma Society Young Clinician-Scientist Grant (IFA), NIH/NEI K23EY035734 (IFA), NIH/NEI R01EY022305 (JLW)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 626. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      McKenzie Gillison, Anna Larson, Shi Song Rong, Janey L Wiggs, Inas F Aboobakar; Characterization of glaucoma-relevant phenotypes in an Angiopoietin-like 7 zebrafish knockout line. Invest. Ophthalmol. Vis. Sci. 2024;65(7):626.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Rare coding variants in the Angiopoietin-like 7 (ANGPTL7) gene are associated with lower intraocular pressure (IOP) and decreased odds of developing primary open-angle glaucoma (POAG), likely through an impact on conventional aqueous outflow. To further assess the protective mechanism in vivo, we characterized glaucoma-relevant phenotypes in an ANGPTL7 zebrafish knockout line.

Methods : Commercially available ANGPTL7 knockout fish (ZFIN ZDB-ALT-131217-15866) were outcrossed to AB genetic background fish to generate wild-type (WT), heterozygous (HET), and homozygous knockout (KO) lines. Survival at 5 days post-fertilization (dpf), eye area and visual motor response using the ZebraBox system were compared between WT, HET and KO lines using two-way ANOVA (n=96 for each). WT, HET, and KO fish were also euthanized at 5, 10, and 20 dpf, preserved in Davidson’s fixative and submitted for histology using toluidine blue (n=15 for each). Additionally, immunohistochemistry was performed to evaluate Angptl7 localization in cryopreserved WT and KO fish at 5, 10 and 20 dpf (n=3 for each). IOP was measured using the Tonolab device (iCare USA) in adult (9 months old) WT (n=13) and KO (n=8) fish following induction of anesthesia with MS-222 and compared using a two-tailed t-test.

Results : Compared to WT fish at 5 dpf, HET fish and KO fish had 48% and 96% lower ANGPTL7 expression, respectively (p<0.001). There were no significant differences in survival, eye area or visual motor response among the three lines at 5dpf (p>0.05 for all). Immunohistochemistry revealed specific localization of ANGPTL7 to the developing zebrafish outflow tract. Compared to WT fish, HET and KO fish demonstrated reduced accumulation of fluid in the developing outflow tract on histology, suggesting that reduced ANGPTL7 expression either increases aqueous outflow or reduces production. There was a trend towards reduced IOP in the KO line compared to WT (10.5 vs 12.5 mm Hg), though this did not reach statistical significance (p=0.12).

Conclusions : Knockout of ANGPTL7 leads to histological changes in the developing outflow pathway and reduced IOP in vivo, further suggesting that reduced ANGPTL7 expression may serve as a viable therapeutic strategy for ocular hypertension and glaucoma. This study further highlights the utility of zebrafish as a high throughput model system for functional characterization of glaucoma-associated genes.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×